Diseases

Prometic Life sciences asserted that the U.S Food and Drug Adminstration has granted a Rare Pediatric Disease Designation to its Inter-Alpha-Inhibitor-Proteins for the treatment of…
Read More...

Vanda Pharmaceuticals asserted that HETLIOZ which is a circadian regulator exhibited significant and clinically meaningful benefits in symptoms of jet lag disorder. Jet lag disorder…
Read More...

Benitec Biopharma which is a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its patented gene-silencing technology named ddRNAi…
Read More...

Trovagene which is a precision medicine biotechnology company developing targeted cancer therapeutics asserted that the initial patient successfully completed first cycle 1 Treatment in…
Read More...

Lyric Pharmaceuticals which is a biopharmaceutical company asserted the completion of enlisting for PROMOTE Study which is an international multi-center, randomized, controlled Phase 2…
Read More...

Global pharmaceutical company, Glenmark affirmed poster presentations of data from clinical studies of Ryaltris which is an investigational fixed-dose combination nasal spray for…
Read More...

Aimmune Therapeutics which is a bio pharmaceutical company curating treatments for fatal food allergies, announced that the results of its pivotal Phase 3 PALISADE trial of AR101 for…
Read More...

London and New York based gene therapy company, MeiraGTx declared that the European Medicines Agency has extended Priority Medicines (PRIME) designation to MeiraGTx’s gene therapy…
Read More...

Unum Therapeutics  which is a clinical-stage bio pharmaceutical company focused on the development of novel immunotherapy products designed to utilize the power of  patient's immune…
Read More...

Cardiovascular Systems, Inc which is a medical device company curating and developing breakthrough interventional treatment systems for patients with peripheral and coronary artery…
Read More...

Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...

The Biotechnology Organization and MichBio support Governor Rick Snyder for signing critical legislation to pave way for the substitution of Interchangeable biologic medicines conveying…
Read More...

CSA medical declared the completion of the treatment phase for its ongoing study The Safety and Feasibility Study of RejuvenAir for Treating Chronic Bronchitis Patients (NCT02483637).…
Read More...

JHL Biotech has asserted that the Dutch Healthcare Authority has sanctioned a Clinical Trial Application for JHL's dornase alfa biosimilar, JHL1922 to enhance pulmonary function of…
Read More...

Ionis Pharmaceuticals which is a leader in antisense therapeutics asserted that the positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx      in people with early…
Read More...

Ageless Forever asserts to offer GAINSWave which is an innovative noninvasive medical therapy that utilizes low-intensity shockwave therapy to treat Erectile Dysfunction symptoms. It…
Read More...

Regeneron Pharmaceuticals and Sanofi claimed that the U.S Food and Drug Administration has considered to assess the supplemental Biologics License Application (sBLA) of DUPIXENT as an…
Read More...

Mylan set to introduce two new HIV treatments namely, Symfi Lo and Cimduo that was sanctioned in February by the U.S Food and Drug Administration. Introducing Symfi Lo in the coming…
Read More...

Jazz Pharmaceuticals affirmed that the U.S Food and Drug Administration has conceded for filing with standard review the company's New Drug Application requesting marketing approval for…
Read More...

Concert Pharmaceuticals asserted the next development candidate CTP-692, a novel drug for adjunctive treatment of schizophrenia, a devastating, chronic illness with significant unmet…
Read More...